Free Trial
→ Analyst nicknamed “The Prophet” issues new warning for America (From Stansberry Research) (Ad)tc pixel Free RTW Stock Alerts

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 2.31 -0.01 (-0.43%)
As of 05:33 AM Eastern
Compare

RTW vs. RSE, CIP, PGIT, DNE, and UTLI

Should you buy RTW Biotech Opportunities stock or one of its competitors? RTW Biotech Opportunities's main competitors and comparable companies include Riverstone Energy (RSE), CIP Merchant Capital (CIP), Premier Global Infrastructure Trust PLC (PGIT.L) (PGIT), Dunedin Enterprise Investment Trust (DNE), and UIL Finance (UTLI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does RTW Biotech Opportunities compare to Riverstone Energy?

RTW Biotech Opportunities (LON:RTW) and Riverstone Energy (LON:RSE) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Riverstone Energy'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Riverstone Energy Neutral

RTW Biotech Opportunities has higher revenue and earnings than Riverstone Energy. Riverstone Energy is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Riverstone Energy£26.25M1.10£78.63M-£8.84N/A

RTW Biotech Opportunities has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Riverstone Energy has a beta of 0.14201292, meaning that its stock price is 86% less volatile than the broader market.

RTW Biotech Opportunities has a net margin of 249.72% compared to Riverstone Energy's net margin of -1.67%. RTW Biotech Opportunities' return on equity of 52.83% beat Riverstone Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities249.72% 52.83% -0.47%
Riverstone Energy -1.67%-3.23%-0.22%

2.8% of RTW Biotech Opportunities shares are held by institutional investors. Comparatively, 7.5% of Riverstone Energy shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by company insiders. Comparatively, 66.9% of Riverstone Energy shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

RTW Biotech Opportunities beats Riverstone Energy on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to CIP Merchant Capital?

RTW Biotech Opportunities (LON:RTW) and CIP Merchant Capital (LON:CIP) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled CIP Merchant Capital'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
CIP Merchant Capital Neutral

2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

RTW Biotech Opportunities has a net margin of 249.72% compared to CIP Merchant Capital's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 52.83% beat CIP Merchant Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities249.72% 52.83% -0.47%
CIP Merchant Capital N/A N/A N/A

RTW Biotech Opportunities has higher revenue and earnings than CIP Merchant Capital. CIP Merchant Capital is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
CIP Merchant Capital£8.87M0.00N/A£13.70N/A

Summary

RTW Biotech Opportunities beats CIP Merchant Capital on 6 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Premier Global Infrastructure Trust PLC (PGIT.L)?

RTW Biotech Opportunities (LON:RTW) and Premier Global Infrastructure Trust PLC (PGIT.L) (LON:PGIT) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

RTW Biotech Opportunities has higher revenue and earnings than Premier Global Infrastructure Trust PLC (PGIT.L). Premier Global Infrastructure Trust PLC (PGIT.L) is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Premier Global Infrastructure Trust PLC (PGIT.L)-£2.54M0.00N/A-£40.70N/A

RTW Biotech Opportunities has a net margin of 249.72% compared to Premier Global Infrastructure Trust PLC (PGIT.L)'s net margin of 0.00%. RTW Biotech Opportunities' return on equity of 52.83% beat Premier Global Infrastructure Trust PLC (PGIT.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities249.72% 52.83% -0.47%
Premier Global Infrastructure Trust PLC (PGIT.L) N/A N/A N/A

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Premier Global Infrastructure Trust PLC (PGIT.L)'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Premier Global Infrastructure Trust PLC (PGIT.L) Neutral

Summary

RTW Biotech Opportunities beats Premier Global Infrastructure Trust PLC (PGIT.L) on 7 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Dunedin Enterprise Investment Trust?

RTW Biotech Opportunities (LON:RTW) and Dunedin Enterprise Investment Trust (LON:DNE) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Dunedin Enterprise Investment Trust'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Dunedin Enterprise Investment Trust Neutral

RTW Biotech Opportunities has higher revenue and earnings than Dunedin Enterprise Investment Trust. Dunedin Enterprise Investment Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Dunedin Enterprise Investment Trust£1.99M0.00£1.56M£28.41N/A

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. Comparatively, 32.6% of Dunedin Enterprise Investment Trust shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by company insiders. Comparatively, 68.6% of Dunedin Enterprise Investment Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

RTW Biotech Opportunities has a net margin of 249.72% compared to Dunedin Enterprise Investment Trust's net margin of 74.24%. RTW Biotech Opportunities' return on equity of 52.83% beat Dunedin Enterprise Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities249.72% 52.83% -0.47%
Dunedin Enterprise Investment Trust 74.24%3.62%2.87%

RTW Biotech Opportunities has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Dunedin Enterprise Investment Trust has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market.

Summary

RTW Biotech Opportunities beats Dunedin Enterprise Investment Trust on 6 of the 10 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to UIL Finance?

UIL Finance (LON:UTLI) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

RTW Biotech Opportunities has higher revenue and earnings than UIL Finance.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UIL Finance£3.70M6.98N/AN/AN/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

UIL Finance has a beta of 0.20071709, meaning that its stock price is 80% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

RTW Biotech Opportunities has a net margin of 249.72% compared to UIL Finance's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 52.83% beat UIL Finance's return on equity.

Company Net Margins Return on Equity Return on Assets
UIL FinanceN/A N/A 3.35%
RTW Biotech Opportunities 249.72%52.83%-0.47%

In the previous week, UIL Finance's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
UIL Finance Neutral
RTW Biotech Opportunities Neutral

11.1% of UIL Finance shares are held by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

RTW Biotech Opportunities beats UIL Finance on 5 of the 8 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

Export
MetricRTW Biotech OpportunitiesCapital Markets IndustryFinance SectorLON Exchange
Market Cap£7.46M£5.17B£13.43B£2.84B
Dividend YieldN/A7.56%6.03%6.26%
P/E Ratio0.0429.5124.45366.80
Price / Sales0.031,192.84498.3689,149.74
Price / Cash0.3247.6729.4627.89
Price / Book0.013.502.716.78
Net Income£14.09B£415.67M£1.31B£5.89B
7 Day Performance-0.43%-0.13%-0.25%-0.63%
1 Month Performance-4.55%-2.66%-3.18%-1.11%
1 Year Performance48.55%10.90%11.18%23.04%

RTW Biotech Opportunities Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 2.31
-0.4%		N/A+49.7%£7.46M£250.89M0.044,971
RSE
Riverstone Energy
N/AGBX 572
+0.4%		N/A-34.6%£27.58M£26.25MN/AN/A
CIP
CIP Merchant Capital
N/AN/AN/AN/A£27.50M£8.87M3.65N/A
PGIT
Premier Global Infrastructure Trust PLC (PGIT.L)
N/AN/AN/AN/A£26.23M-£2.54MN/AN/A
DNE
Dunedin Enterprise Investment Trust
N/AN/AN/AN/A£26.15M£1.99M16.72N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:RTW) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners
They're not telling you how bad this could get
Valuations have reached levels seen only a handful of times in the past century, while debt concerns and tarif...
Parkview Capital Group | Sponsoredtc pixel
This smart glasses tech is bringing the screen to your eyes
Global AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...
The Tomorrow Investor | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...
Paradigm Press | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...
Banyan Hill Publishing | Sponsoredtc pixel
Analyst nicknamed “The Prophet” issues new warning for America
Whitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...
Stansberry Research | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel